Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 22 Oct 2017 Planned End Date changed from 1 May 2018 to 1 Jun 2018.
- 22 Oct 2017 Planned primary completion date changed from 1 Apr 2018 to 1 May 2018.
- 22 Oct 2017 Status changed from not yet recruiting to recruiting.